NEW YORK, March 12, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on hemostatic medical device technologies, today announced that a retrospective ...

Presenters: David J. Kleiman, NRP; Tyler N. Carruth, MPA-C; James Infanzon, MD; Marvin E. Nix, MD; Brian J. Goldstone, DO Date and Time: Saturday, March 14, 5:00-6:00 ...

Before we begin, I'd like to remind everyone that during this call, certain statements made are forward-looking statements ...

Each morning Gaynor Crossan lovingly prepares her husband of 57 years for the day ahead. It's a complicated process that takes nearly an hour. Graham is 80 years old and has advanced Motor Neurone ...

Ellipsis Health partners with PromptWell to boost enrollment in patient care programs, while CaryHealth teams up with ...

In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and the brain later in life, investigators at Johns Hopkins Medicine and ...

Global Youth Redefining The Future Of Humanitarianism Through AI. On March 12, 2026, the annual Humanitarian Networks and ...

In The Jerusalem Post studio, billionaire WorldQuant founder Igor Tulchinsky spoke with unusual candor about October 7, Chabad, AI, and why he thinks Israel can become a “quant nation.” ...

Throughout their yearlong spacefaring adventures and academic endeavors aboard USS Athena, the young cadets of “Starfleet ...

Understanding the neurobiology of trauma, from the silent Broca’s area to the overactive amygdala, can be a pivotal step in moving from survival to a validated recovery.

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

Metabolic-associated steatotic liver disease (MASLD) is a clinically heterogeneous condition with highly variable outcomes ...